https://ecancer.org/en/video/12026-no-os-improvement-over-chemo-from-capivasertib-plus-paclitaxel-in-advanced-tnbc
No OS improvement over chemo from capivasertib plus paclitaxel in advanced TNBC - ecancer
Dr McArthur talks to ecancer at ESMO 2024 about negative trial results from the phase three study CAPItello-290, looking at targeted treatment for triple negati
no osadvanced tnbcimprovementchemoplus
https://oncodaily.com/drugs/sacituzumab-193201
Sacituzumab Tirumotecan Earns Approval in China in Pretreated Advanced TNBC - OncoDaily
Nov 30, 2024 - Sacituzumab Tirumotecan Earns Approval in China in Pretreated Advanced TNBC / antibody-drug conjugate, cancer, China's National Medical Products
in chinaadvanced tnbcearnsapprovaloncodaily